HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Monge Selected Research

BR 76 (BR 1376)

8/2011New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Monge Research Topics

Disease

8Obesity
06/2012 - 01/2004
6Hypoxia (Hypoxemia)
01/2011 - 01/2005
5Tuberculosis (Tuberculoses)
06/2011 - 09/2008
5Neoplasms (Cancer)
01/2011 - 04/2004
4Malaria
04/2013 - 01/2007
3Neglected Diseases
08/2013 - 06/2009
3Chagas Disease (American Trypanosomiasis)
08/2013 - 01/2009
2Leishmaniasis
04/2013 - 08/2011
2Edema (Dropsy)
04/2011 - 12/2007
1Necrosis
01/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017
1Type 2 Diabetes Mellitus (MODY)
06/2012
1Atherosclerotic Plaque (Atheroma)
07/2011
1Adenocarcinoma
05/2007
1Carcinoma (Carcinomatosis)
05/2007
1Colonic Neoplasms (Colon Cancer)
05/2007

Drug/Important Bio-Agent (IBA)

5QuinoxalinesIBA
01/2018 - 01/2007
4LigandsIBA
11/2010 - 04/2004
3Antitubercular AgentsIBA
06/2011 - 09/2008
3Cytotoxins (Cytolysins)IBA
01/2011 - 08/2006
3OxidesIBA
08/2010 - 01/2007
3Tirapazamine (SR 4233)IBA
05/2010 - 08/2006
3Neuropeptide YIBA
01/2005 - 01/2004
2quinoxaline-2-carboxamide-1,4-di-N-oxideIBA
01/2018 - 01/2017
2quindoxinIBA
08/2013 - 06/2011
2Antimalarials (Antimalarial Agents)IBA
04/2013 - 08/2011
2Isoniazid (Ftivazide)FDA LinkGeneric
06/2011 - 09/2008
2CarrageenanIBA
04/2011 - 12/2007
2melanin-concentrating hormone (melanin concentrating hormone)IBA
11/2010 - 01/2008
2Biological ProductsIBA
06/2010 - 01/2007
2Pharmaceutical PreparationsIBA
02/2009 - 09/2008
2melanin-concentrating hormone receptorIBA
01/2008 - 01/2008
2MetalsIBA
08/2006 - 04/2004
1PhosphatidylserinesIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1EstersIBA
01/2017
1Histamine (Histamine Dihydrochloride)FDA Link
06/2012
1BR 76 (BR 1376)IBA
08/2011
1quinoxaline-2-carbonitrileIBA
08/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2011
1Nitric Oxide DonorsIBA
07/2011
1Tocopherols (Tocopherol)IBA
07/2011
1LipidsIBA
07/2011
1Lipoproteins (Lipoprotein)IBA
07/2011
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2011
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
04/2011
1phenazineFDA Link
01/2011
1hydroxide ionIBA
01/2011
1Iron CompoundsIBA
11/2010
1IronIBA
11/2010
1Melanins (Melanin)IBA
11/2010
1quinoxaline-2-carboxamideIBA
10/2010
1CarcinogensIBA
07/2010
1DNA (Deoxyribonucleic Acid)IBA
05/2010
17- chloro- 2- thienylcarbonyl- 3- trifluoromethylquinoxaline 1,4-dioxideIBA
05/2010
11-Propanol (Propanol)IBA
10/2009
1AcidsIBA
06/2009
1MisonidazoleIBA
02/2009
1RB 90740IBA
02/2009
1Proteins (Proteins, Gene)FDA Link
01/2009
1Rifampin (Rifampicin)FDA LinkGeneric
09/2008
1pretomanidIBA
09/2008
1AerosolsIBA
09/2008
1CopperIBA
01/2008
1AmidesIBA
01/2008
1Urea (Carbamide)FDA LinkGeneric
06/2007
1FlavanonesIBA
05/2007
1Estrogen ReceptorsIBA
05/2007
1FlavonesIBA
05/2007
1ChalconesIBA
05/2007
1ProdrugsIBA
08/2006
1Vanadates (Orthovanadate)IBA
08/2006
13- aminoquinoxaline- 2- carbonitrile- N1,N4- dioxideIBA
08/2006
17- chloro- 3- (((N,N- dimethylamino)propyl)amino)- 2- quinoxalinecarbonitrile- 1,4- di- N- oxideIBA
01/2005
1HydrazinesIBA
09/2004
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
04/2004

Therapy/Procedure

2Therapeutics
01/2011 - 06/2010